269 related articles for article (PubMed ID: 14629653)
41. [Comparison of the diagnostic value of telomerase activity with CEA level in benign and malignant pleural effusions].
Yang Z; Xie C
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Apr; 24(4):201-3. PubMed ID: 11802962
[TBL] [Abstract][Full Text] [Related]
42. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
[TBL] [Abstract][Full Text] [Related]
43. Diagnosis of pleural effusions. Experience with clinical studies, 1986 to 1990.
Marel M; Stastny B; Melínová L; Svandová E; Light RW
Chest; 1995 Jun; 107(6):1598-603. PubMed ID: 7781353
[TBL] [Abstract][Full Text] [Related]
44. Diagnostic value of interleukin 21 and carcinoembryonic antigen levels in malignant pleural effusions.
Bunjhoo H; Wang ZY; Chen HL; Cheng S; Xiong WN; Xu YJ; Cao Y
Asian Pac J Cancer Prev; 2012; 13(7):3495-9. PubMed ID: 22994784
[TBL] [Abstract][Full Text] [Related]
45. Pleural IFN-γ release assay combined with biomarkers distinguished effectively tuberculosis from malignant pleural effusion.
Tang Y; Zhang J; Huang H; He X; Zhang J; Ou M; Li G; Zeng C; Ye T; Ren L; Liu Y; Zhang G
BMC Infect Dis; 2019 Jan; 19(1):55. PubMed ID: 30651075
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of pleural fluid survivin and XIAP for the diagnosis of malignant pleural effusion.
Li J; Li ZN; Bao QL; Ge LP; Li XQ; Chen P
Tumour Biol; 2012 Oct; 33(5):1803-10. PubMed ID: 22696161
[TBL] [Abstract][Full Text] [Related]
47. Interleukin-1 beta in pleural fluids of different etiologies. Its role as inflammatory mediator in empyema.
Silva-Mejías C; Gamboa-Antiñolo F; López-Cortés LF; Cruz-Ruiz M; Pachón J
Chest; 1995 Oct; 108(4):942-5. PubMed ID: 7555165
[TBL] [Abstract][Full Text] [Related]
48. Diagnostic Accuracy of Pleural Fluid Cytology, Carcinoembryonic Antigen and C-Reactive Protein Together in Patients With Pulmonary Metastases and Malignant Pleural Effusion.
Basso SMM; Del Conte A; Zuccon U; Sulfaro SC; Fanti G; Maffeis F; Ubiali P; Ermani M; Lumachi F
Anticancer Res; 2020 Oct; 40(10):5877-5881. PubMed ID: 32988918
[TBL] [Abstract][Full Text] [Related]
49. Limited additive value of pleural fluid carcinoembryonic antigen level in malignant pleural effusion.
Riantawan P; Sangsayan P; Bangpattanasiri K; Rojanaraweewong P
Respiration; 2000; 67(1):24-9. PubMed ID: 10705258
[TBL] [Abstract][Full Text] [Related]
50. CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.
Wang XF; Wu YH; Wang MS; Wang YS
Asian Pac J Cancer Prev; 2014; 15(1):363-8. PubMed ID: 24528057
[TBL] [Abstract][Full Text] [Related]
51. Parapneumonic effusions.
Light RW; Girard WM; Jenkinson SG; George RB
Am J Med; 1980 Oct; 69(4):507-12. PubMed ID: 7424940
[TBL] [Abstract][Full Text] [Related]
52. Prevalence of human immunodeficiency virus infection: its impact on the diagnostic yields in exudative pleural effusions at the Kenyatta National Hospital, Nairobi.
Owino EA; McLigeyo SO; Gathua SN; Nyong'o A
East Afr Med J; 1996 Sep; 73(9):575-8. PubMed ID: 8991236
[TBL] [Abstract][Full Text] [Related]
53. Pleural fluid pH: diagnostic, therapeutic, and prognostic value.
Houston MC
Am J Surg; 1987 Sep; 154(3):333-7. PubMed ID: 3307471
[TBL] [Abstract][Full Text] [Related]
54. Atypical Pleural Fluid Profiles in Tuberculous Pleural Effusion: Sequential Changes Compared with Parapneumonic and Malignant Pleural Effusions.
Kim CH; Lee SY; Lee YD; Yoo SS; Lee SY; Cha SI; Park JY; Lee J
Intern Med; 2016; 55(13):1713-9. PubMed ID: 27374670
[TBL] [Abstract][Full Text] [Related]
55. [Diagnostic value of pleural fluid and serum procalcitonin levels in the diagnosis of parapneumonic pleural effusion].
Doğan C; Bilaçeroğlu S; Çirak AK; Özsöz A; Özbek D
Tuberk Toraks; 2013; 61(2):103-9. PubMed ID: 23875587
[TBL] [Abstract][Full Text] [Related]
56. [Parapneumonic pleural effusion: difficulties in making therapeutic decisions].
Chudzicka A; Chciałowski A
Pol Arch Med Wewn; 2007; 117(1-2):44-8. PubMed ID: 17642206
[TBL] [Abstract][Full Text] [Related]
57. Use of pleural fluid C-reactive protein in diagnosis of pleural effusions.
Yilmaz Turay U; Yildirim Z; Türköz Y; Biber C; Erdoğan Y; Keyf AI; Uğurman F; Ayaz A; Ergün P; Harputluoğlu M
Respir Med; 2000 May; 94(5):432-5. PubMed ID: 10868705
[TBL] [Abstract][Full Text] [Related]
58. CEA, CA 15-3 and CYFRA 21-1 in serum and pleural fluid of patients with pleural effusions.
Romero S; Fernández C; Arriero JM; Espasa A; Candela A; Martín C; Sánchez-Payá J
Eur Respir J; 1996 Jan; 9(1):17-23. PubMed ID: 8834328
[TBL] [Abstract][Full Text] [Related]
59. Pleural fluid adenosine deaminase/serum C-reactive protein ratio for the differentiation of tuberculous and parapneumonic effusions with neutrophilic predominance and high adenosine deaminase levels.
Lee J; Yoo SS; Lee SY; Cha SI; Park JY; Kim CH
Infection; 2017 Feb; 45(1):59-65. PubMed ID: 27488820
[TBL] [Abstract][Full Text] [Related]
60. Significance of adenosine deaminase in diagnosing tuberculous pleural effusion.
Devkota KC; Shyam BK; Sherpa K; Ghimire P; Sherpa MT; Shrestha R; Gautam S
Nepal Med Coll J; 2012 Jun; 14(2):149-52. PubMed ID: 23671968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
